Back to OTIC Stock Lookup

Otonomy (OTIC) – Company Press Releases

May 4, 2021 07:30 AM Otonomy to Report First Quarter 2021 Financial Results and Provide Corporate Update
Apr 28, 2021 07:30 AM Otonomy and AGTC to Present Preclinical Proof-of-Concept Results for OTO-825 Gene Therapy at ASGCT Annual Meeting
Apr 19, 2021 07:30 AM Otonomy Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Apr 7, 2021 10:02 PM Otonomy Announces Pricing of $30.1 Million Public Offering
Apr 7, 2021 04:06 PM Otonomy Announces Proposed Public Offering
Apr 6, 2021 07:30 AM Otonomy to Present at the Needham Virtual Healthcare Conference
Apr 5, 2021 07:30 AM Otonomy Announces Presentation of OTO-313 Clinical Results at American Neurotology Society Annual Meeting
Mar 25, 2021 07:30 AM Otonomy Initiates Phase 2 Clinical Trial of OTO-313 in Tinnitus
Feb 25, 2021 07:30 AM Otonomy to Participate in Three Upcoming Investor Conferences
Feb 22, 2021 07:00 AM Otonomy Announces Top-Line Results for the Phase 3 Clinical Trial of OTIVIDEX® in Patients with Ménière's Disease
Feb 17, 2021 07:30 AM Otonomy Announces Multiple Presentations at Association for Research in Otolaryngology Annual Meeting
Feb 11, 2021 04:16 PM Otonomy Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
Feb 4, 2021 07:30 AM Otonomy to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update
Jan 5, 2021 07:30 AM Otonomy to Participate in the H.C. Wainwright BioConnect 2021 Virtual Conference
Dec 17, 2020 07:00 AM Otonomy Reports Positive Top-Line Results from Phase 1/2 Clinical Trial of OTO-413 in Patients with Hearing Loss
Nov 30, 2020 07:30 AM Otonomy Provides Update on OTIVIDEX® and OTO-313 Programs
Nov 16, 2020 07:30 AM Otonomy to Participate in Two Upcoming Investor Conferences
Nov 4, 2020 04:17 PM Otonomy Reports Third Quarter 2020 Financial Results and Provides Corporate Update
Oct 28, 2020 07:30 AM Otonomy to Report Third Quarter 2020 Financial Results and Provide Corporate Update
Oct 2, 2020 07:30 AM Otonomy Completes Patient Enrollment for Phase 3 Trial of OTIVIDEX® in Ménière’s Disease
Sep 2, 2020 07:30 AM Otonomy to Participate in Four Upcoming Investor Conferences
Aug 4, 2020 04:22 PM Otonomy Reports Second Quarter 2020 Financial Results and Provides Corporate Update
Aug 3, 2020 07:30 AM Otonomy Announces Exclusive License Agreement with Kyorin for Novel Compound in OTO-6XX Hearing Loss Program
Jul 28, 2020 04:05 PM Otonomy to Report Second Quarter 2020 Financial Results and Provide Corporate Update
Jul 13, 2020 04:01 PM Otonomy Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Jul 9, 2020 09:00 AM Otonomy Announces Pricing of $60.1 Million Public Offering
Jul 8, 2020 04:03 PM Otonomy Announces Proposed Public Offering
Jul 6, 2020 04:04 PM Otonomy Reports Positive Top-Line Results from Phase 1/2 Clinical Trial of OTO-313 in Patients with Tinnitus
Jul 6, 2020 04:02 PM Otonomy Provides Update on OTIVIDEX® Program
Jun 15, 2020 04:05 PM Otonomy Provides Update on Clinical Trials and Development Programs
Jun 11, 2020 07:30 AM Otonomy to Present at Raymond James 2020 Human Health Innovation Conference
Jun 10, 2020 07:30 AM Otonomy to Hold Virtual Annual Meeting of Stockholders for 2020
Jun 8, 2020 07:30 AM Otonomy to Host Pipeline Program Update Conference Call and Webcast
Jun 4, 2020 08:00 AM Silverback Therapeutics Appoints Vickie L. Capps to Board of Directors and Audit Committee Chair
May 12, 2020 08:00 AM Otonomy and AGTC Present Preclinical Results Supporting Selection of Product Candidate for GJB2 Gene Therapy Hearing Loss Program
May 7, 2020 07:30 AM Otonomy Reports First Quarter 2020 Financial Results and Provides Corporate Update
Apr 9, 2020 07:30 AM Otonomy Provides Business Update Related to COVID-19 Pandemic
Feb 27, 2020 04:15 PM Otonomy Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
Feb 24, 2020 07:30 AM Otonomy to Present at Two Upcoming Investor Conferences
Feb 20, 2020 07:30 AM Otonomy to Report Fourth Quarter and Full Year 2019 Financial Results and Provide Corporate Update
Jan 28, 2020 07:30 AM Otonomy Presents Preclinical Results for GJB2 Gene Therapy Collaboration and Cisplatin Otoprotection Program
Jan 23, 2020 07:30 AM Otonomy Announces Multiple Presentations at Association for Research in Otolaryngology Annual Meeting
Jan 9, 2020 07:30 AM Otonomy Provides Corporate and Product Pipeline Update
Nov 26, 2019 04:05 PM Otonomy to Participate in Two Upcoming Investor Conferences
Nov 5, 2019 04:13 PM Otonomy Reports Third Quarter 2019 Financial Results and Provides Corporate Update
Oct 29, 2019 04:05 PM Otonomy to Report Third Quarter 2019 Financial Results and Provide Corporate Update
Oct 1, 2019 07:30 AM AGTC and Otonomy Announce Strategic Collaboration to Develop and Commercialize Gene Therapy for Congenital Hearing Loss
Sep 26, 2019 04:05 PM Otonomy to Present at the Cantor Global Healthcare Conference
Sep 17, 2019 07:30 AM Otonomy Initiating Phase 1/2 Clinical Trial of OTO-413 in Hearing Loss
Aug 1, 2019 04:20 PM Otonomy Reports Second Quarter 2019 Financial Results and Provides Corporate Update

Back to OTIC Stock Lookup